Since changes in ECM proteins and their organization around the tumor tissue are a hallmark of cancer progression, we turned to investigate the small leucine-rich ECM protein biglycan whose levels in the secretome increased manyfold upon L1 transfection (Supplementary Table S1). The gene discussed is BGN; the disease is cancer.